Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting IRAK4 in Chronic Lymphocytic Leukemia

NCT07741695 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07741695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting IRAK4 in Chronic Lymphocytic Leukemia
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2027
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia (cll)